Vaccine Market 2014 - 2020

  • ID: 3782367
  • Report
  • Region: Global
  • 110 pages
  • Zion Market Research
1 of 4

FEATURED COMPANIES

  • CSL Limited
  • Emergent BioSolutions Inc
  • GlaxoSmithKline plc
  • Johnson and Johnson
  • MedImmune LLC
  • Merck and Company
  • MORE
Vaccine Market by Technology (Inactivated, Subunit, Conjugate, Live Attenuated, Toxoid, and Dendritic Cell Synthetic), Type (Therapeutic, Preventive), Indication (Allergy, Infectious Disease, Tumors and Others) for Infants, Early Aged, and Post Aged: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2014 - 2020'

The report covers forecast and analysis for the vaccine market on a global and regional level. The study provides historic data of 2014 along with a forecast from 2015 to 2020 based revenue (USD Million). The study includes drivers and restraints for the market along with the impact they have on the demand over the forecast period. Additionally, the report includes study of opportunities available in the vaccine market on a global level.

In order to give the users of this report a comprehensive view on the vaccine market, we have included a detailed competitive scenario, and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the vaccine market has also been included. The study encompasses a market attractiveness analysis, wherein technology segments are benchmarked based on their market size, growth rate and general attractiveness.

The study provides a decisive view on the vaccine market by segmenting the market based on technology, type, end-users, indication and region. Inactivated, subunit, conjugate, live attenuated, toxoid, dendritic cell and synthetic are the technological segments of the vaccine market. Preventive and therapeutic are the two types of vaccine. All the segments have been analyzed based on present and future trends and the market is estimated from 2014 to 2020. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East and Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India and Brazil.

The report covers detailed competitive outlook including company profiles of the key participants operating in the global market. Key players profiled in the report include Pfizer, CSL Limited, GlaxoSmithKline, plc, MedImmune, LLC, Novartis AG, Sanofi Pasteur, Merck and Company, Johnson and Johnson and Emergent BioSolutions Inc among others.

This report segments the vaccine market as follows:

Vaccine Market: Technology Segment Analysis

- Inactivated
- Subunit
- Conjugate
- Live Attenuated
- Toxoid
- Dendritic Cell
- Synthetic

Vaccine Market: Type Segment Analysis

- Therapeutic vaccine
- Preventive vaccine

Vaccine Market: End user Segment Analysis

- Infants
- Early aged
- Post aged

Vaccine Market: Indications Segment Analysis

- Allergy
- Infectious disease
- Tumors
- Others

Vaccine Market: Regional Segment Analysis

- North America
- - US
- Europe
- - Germany
- - France
- - UK
- Asia Pacific
- - China
- - Japan
- - India
- Latin America
- - Brazil
- Middle East and Africa

PLEASE NOTE: This report will be delivered between 24-48 hours after confirmation of payment.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • CSL Limited
  • Emergent BioSolutions Inc
  • GlaxoSmithKline plc
  • Johnson and Johnson
  • MedImmune LLC
  • Merck and Company
  • MORE
1. Introduction
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
1.3.1. Market research process
1.3.2. Market research methodology

2. Executive Summary
2.1. Global market revenue, 2014 - 2020(USD Million)
2.2. Global vaccine market: Snapshot

3. Vaccine Market - Global and Industry Analysis
3.1. Vaccine : Market dynamics
3.2. Market drivers
3.2.1. Drivers of global vaccine market: Impact analysis
3.2.2. Rise in frequency of diseases worldwide
3.2.3. Introduction of new vaccines
3.3. Market restraints
3.3.1. Restraints of global vaccine market: Impact analysis
3.3.2. High maintenance for preservation of vaccines
3.3.3. Strict laws of regulatory for production of vaccine
3.3.4. Huge expense for R&D of vaccines
3.4. Opportunities
3.4.1. Increasing demand from developing countries
3.4.2. Government initiatives
3.4.3. Development of new vaccines
3.5. Porter’s five forces analysis
3.6. Market Attractiveness Analysis
3.6.1. Market attractiveness analysis by technology segment
3.6.2. Market attractiveness analysis by type segment
3.6.3. Market attractiveness analysis by end user segment
3.6.4. Market attractiveness analysis by indication segment
3.6.5. Market attractiveness analysis by regional segment

4. Global Vaccine Market - Competitive Landscape
4.1. Company market share, 2014
4.2. Price trend analysis

5. Global Vaccine Market - Technology Segment Analysis
5.1. Global vaccine market: technology overview
5.1.1. Global vaccine market revenue share, by technology, 2014 - 2020
5.2. Inactivated vaccines
5.2.1. Global inactivated vaccines market, by technology, 2014 - 2020 (USD Million)
5.3. Subunit vaccines
5.3.1. Global subunit vaccines market, by technology, 2014 - 2020 (USD Million)
5.4. Conjugate vaccines
5.4.1. Global conjugate vaccines market, by technology, 2014 - 2020 (USD Million)
5.5. Live attenuated vaccines
5.5.1. Global live attenuated vaccines market, by technology, 2014 - 2020 (USD Million)
5.6. Toxoid vaccines
5.6.1. Global toxoid vaccines market, by technology, 2014 - 2020 (USD Million)
5.7. Others (dendritic cell vaccines, synthetic vaccines)
5.7.1. Global others vaccines market, by technology, 2014 - 2020 (USD Million)
6. Global Vaccine Market - Type Segment Analysis
6.1. Global vaccine market: type overview
6.1.1. Global vaccine market revenue share, by type, 2014 - 2020
6.2. Therapeutic vaccines
6.2.1. Global therapeutic vaccines market, by type, 2014 - 2020 (USD Million)
6.3. Preventive vaccines
6.3.1. Global preventive vaccines market, by type, 2014 - 2020 (USD Million)

7. Global Vaccine Market - End users Segment Analysis
7.1. Global vaccine market: type overview
7.1.1. Global vaccine market revenue share, by end users, 2014 - 2020
7.2. Infants
7.2.1. Global infants market, by type, 2014 - 2020 (USD Million)
7.3. Early aged
7.3.1. Global early aged market, by end users, 2014 - 2020 (USD Million)
7.4. Post aged
7.4.1. Global post aged market, by end users, 2014 - 2020 (USD Million)

8. Global Vaccine Market - Indication Segment Analysis
8.1. Global vaccine market: type overview
8.1.1. Global vaccine market revenue share, by indication, 2014 - 2020
8.2. Allergy
8.2.1. Global allergy market, by indication, 2014 - 2020 (USD Million)
8.3. Infectious disease
8.3.1. Global infectious disease market, by indication, 2014 - 2020 (USD Million)
8.4. Others
8.4.1. Global others market, by indication, 2014 - 2020 (USD Million)

9. Global Vaccine market - Regional Segment Analysis
9.1. Global vaccine market: Regional overview
9.1.1. Global vaccine market revenue share by region, 2014 - 2020
9.2. North America
9.2.1. North America vaccine market revenue, by technology, 2014 - 2020 (USD Million)
9.2.2. North America vaccine market revenue, by type, 2014 - 2020 (USD Million)
9.2.3. North America vaccine market revenue, by end user, 2014 - 2020 (USD Million)
9.2.4. U.S.
9.2.4.1. U.S. vaccine market revenue, by technology, 2014 - 2020 (USD Million)
9.2.4.2. U.S. vaccine market revenue, by type, 2014 - 2020 (USD Million)
9.2.4.3. U.S. vaccine market revenue, by end user, 2014 - 2020 (USD Million)
9.3. Europe
9.3.1. Europe vaccine market revenue, by a technology, 2014 - 2020 (USD Million)
9.3.2. Europe vaccine market revenue, by type, 2014 - 2020 (USD Million)
9.3.3. Europe vaccine market revenue, by end user, 2014 - 2020 (USD Million)
9.3.4. Germany
9.3.4.1. Germany vaccine market revenue, by technology, 2014 - 2020 (USD Million)
9.3.4.2. Germany vaccine market revenue, by type, 2014 - 2020 (USD Million)
9.3.4.3. Germany vaccine market revenue, by end user, 2014 - 2020 (USD Million)
9.3.5. France
9.3.5.1. France vaccine market revenue, by technology, 2014 - 2020 (USD Million)
9.3.5.2. France vaccine market revenue, by type, 2014 - 2020 (USD Million)
9.3.5.3. France vaccine market revenue, by end user, 2014 - 2020 (USD Million)
9.3.6. UK
9.3.6.1. UK vaccine market revenue, by technology, 2014 - 2020 (USD Million)
9.3.6.2. UK vaccine market revenue, by type, 2014 - 2020 (USD Million)
9.3.6.3. UK vaccine market revenue, by end user, 2014 - 2020 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific vaccine market revenue, by technology, 2014 - 2020 (USD Million)
9.4.2. Asia Pacific vaccine market revenue, by type, 2014 - 2020 (USD Million)
9.4.3. Asia Pacific vaccine market revenue, by end user, 2014 - 2020 (USD Million)
9.4.4. China
9.4.4.1. China vaccine market revenue, by technology, 2014 - 2020 (USD Million)
9.4.4.2. China vaccine market revenue, by type, 2014 - 2020 (USD Million)
9.4.4.3. China vaccine market revenue, by end user, 2014 - 2020 (USD Million)
9.4.5. Japan
9.4.5.1. Japan vaccine market revenue, by technology, 2014 - 2020 (USD Million)
9.4.5.2. Japan vaccine market revenue, by type, 2014 - 2020 (USD Million)
9.4.5.3. Japan vaccine market revenue, by end user, 2014 - 2020 (USD Million)
9.4.6. India
9.4.6.1. India vaccine market revenue, by technology, 2014 - 2020 (USD Million)
9.4.6.2. India vaccine market revenue, by type, 2014 - 2020 (USD Million)
9.4.6.3. India vaccine market revenue, by end user, 2014 - 2020 (USD Million)
9.5. Latin America
9.5.1. Latin America vaccine market revenue, by technology, 2014 - 2020 (USD Million)
9.5.2. Latin America vaccine market revenue, by type, 2014 - 2020 (USD Million)
9.5.3. Latin America vaccine market revenue, by end user, 2014 - 2020 (USD Million)
9.5.4. Brazil
9.5.4.1. Brazil vaccine market revenue, by technology, 2014 - 2020 (USD Million)
9.5.4.2. Brazil vaccine market revenue, by type, 2014 - 2020 (USD Million)
9.5.4.3. Brazil vaccine market revenue, by end user, 2014 - 2020 (USD Million)
9.6. Middle East and Africa
9.6.1. Middle East and Africa vaccine market revenue, by technology, 2014 - 2020 (USD Million)
9.6.2. Middle East and Africa vaccine market revenue, by type, 2014 - 2020 (USD Million)
9.6.3. Middle East and Africa vaccine market revenue, by end user, 2014 - 2020 (USD Million)

11. Company Profile
10.1. Pfizer
10.1.1. Overview
10.1.2. Financials
10.1.3. Product portfolio
10.1.4. Business strategy
10.1.5. Recent developments
10.2. CSL Limited
10.2.1. Overview
10.2.2. Financials
10.2.3. Product portfolio
10.2.4. Business strategy
10.2.5. Recent developments
10.3. GlaxoSmithKline plc
10.3.1. Overview
10.3.2. Financials
10.3.3. Product portfolio
10.3.4. Business strategy
10.3.5. Recent developments
10.4. MedImmune LLC
10.4.1. Overview
10.4.2. Financials
10.4.3. Product portfolio
10.4.4. Business strategy
10.4.5. Recent developments
10.5. Novartis AG
10.5.1. Overview
10.5.2. Financials
10.5.3. Product portfolio
10.5.4. Business strategy
10.5.5. Recent developments
10.6. Sanofi Pasteur
10.6.1. Overview
10.6.2. Financials
10.6.3. Product portfolio
10.6.4. Business strategy
10.6.5. Recent developments
10.7. Merck and Company
10.7.1. Overview
10.7.2. Financials
10.7.3. Product portfolio
10.7.4. Business strategy
10.7.5. Recent developments
10.8. Johnson and Johnson
10.8.1. Overview
10.8.2. Financials
10.8.3. Product portfolio
10.8.4. Business strategy
10.8.5. Recent developments
10.9. Emergent BioSolutions Inc
10.9.1. Overview
10.9.2. Financials
10.9.3. Product portfolio
10.9.4. Business strategy
10.9.5. Recent developments
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
- CSL Limited
- Emergent BioSolutions Inc
- GlaxoSmithKline plc
- Johnson and Johnson
- MedImmune LLC
- Merck and Company
- Novartis AG
- Pfizer
- Sanofi Pasteur
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll